embecta Announces Major New Commitment to Direct Relief on World Diabetes Day
embecta and Direct Relief announce a significant expansion of their partnership to increase access to diabetes care for communities worldwide ...
embecta Announces Major New Commitment to Direct Relief on World Diabetes Day - Embecta ( NASDAQ:EMBC )
PARSIPPANY, N.J., Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- On World Diabetes Day, embecta Corp. ( "embecta" ) ( NASDAQ:EMBC ) , the largest manufacturer of insulin injection devices in the world, today announced a significant expansion of its partnership with Direct Relief, the leading humanitarian ...
BDX Unveils Portable PureWick System for On-the-Go Incontinence Care
BD expands its PureWick line with a portable system built for discreet, mobile incontinence care, aiming to deepen its home-care reach.
Hologic's Breast Health Rebounds, Takes Spotlight in Buyout Deal
After a strong Q4 rebound, HOLX's Breast Health takes center stage in the company's upcoming private equity takeover.
Becton Dickinson Sees High Single-Digit Profit Growth Ahead, Plans Share Buybacks From Waters Deal - Becton Dickinson ( NYSE:BDX )
Becton Dickinson and Co ( NYSE:BDX ) reported fourth-quarter adjusted earnings of $3.96, beating the consensus of $3.92. The company reported third-quarter 2025 sales of $5.89 billion, slightly below the consensus of $5.90 billion. Revenues increased 8.3% as reported, 7% adjusted FXN, and ...
BD Stock Slips in Pre-Market Despite Q4 Earnings Beat, Margins Up
BDX tops fourth-quarter fiscal 2025 earnings estimates and posts strong margin gains, with growth across all business segments and geographies.
Becton Dickinson ( BDX ) Tops Q4 Earnings and Revenue Estimates
Becton Dickinson (BDX) delivered earnings and revenue surprises of +1.02% and +0.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
McKesson ( MCK ) Surpasses Q2 Earnings Estimates
McKesson (MCK) delivered earnings and revenue surprises of +10.54% and -1.45%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Can Sustained Product Demand Drive BDX Stock Before Q4 Earnings?
BD rides high on product demand across segments, but fourth-quarter fiscal 2025 results may face pressure from global market dynamics.
Merit Medical ( MMSI ) Q3 Earnings and Revenues Surpass Estimates
Merit Medical (MMSI) delivered earnings and revenue surprises of +12.20% and +3.49%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Global Surgical Instrument Tracking Systems Market to Reach USD 751.2 Million by 2030 | MarketsandMarkets™
Delray Beach, FL, Oct. 30, 2025 ( GLOBE NEWSWIRE ) -- The global surgical instrument tracking systems market, valued at US$314.2 million in 2024, stood at US$371.4 million in 2025 and is projected to advance at a resilient CAGR of 15.2% from 2024 to 2030, culminating in a forecasted valuation of ...
Here's Why Becton Dickinson ( BDX ) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
BDX Launches AI-Enabled Platform to Unify Healthcare Connectivity
BD's new AI-driven Incada Platform and upgraded Pyxis Pro system unite connected care, driving its digital healthcare edge.
Plus Therapeutics Updates on CNSide® Diagnostic Platform Launch - Plus Therapeutics ( NASDAQ:PSTV )
Expands commercial readiness and diagnostic, manufacturing footprint Appoints new leadership in commercial strategy and technical operations
Plus Therapeutics Updates on CNSide® Diagnostic Platform Launch
Expands commercial readiness and diagnostic, manufacturing footprint ...
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
BD CFO Set To Exit Company This December, Stock Falls - Becton Dickinson ( NYSE:BDX )
BD ( Becton, Dickinson and Company ) ( NYSE:BDX ) on Wednesday said Chris DelOrefice, executive vice president and chief financial officer ( CFO ) , will depart the company effective December 5. The company is searching to identify a permanent successor.
Can Ion Emerge as ISRG's Vehicle to Tap Ambulatory Care Growth?
Intuitive Surgical's Ion platform gains traction in ambulatory centers, driving 52% growth as outpatient lung diagnostics accelerate.
Looking Into Becton Dickinson & Co's Recent Short Interest - Becton Dickinson ( NYSE:BDX )
Becton Dickinson & Co's ( NYSE:BDX ) short interest as a percent of float has fallen 10.81% since its last report. According to exchange reported data, there are now 3.83 million shares sold short, which is 1.32% of all regular shares that are available for trading.
BD Stock Down Despite Making Progress in the Treatment of PAD Lesions
BDX advances PAD care with first patient enrolled in the XTRACT Registry using its dual-action Rotarex system.
BD Stock Down Despite Tie-Up to Boost Single-Cell Sequencing Workflow
BDX teams with Opentrons to automate single-cell sequencing, advancing its multiomics and biosciences strategy.
Why Becton Dickinson ( BDX ) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
BD and Opentrons Collaborate to Accelerate Single-Cell Multiomics Discoveries with Robotic Automation - Becton Dickinson ( NYSE:BDX )
FRANKLIN LAKES, N.J., Oct. 8, 2025 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) ( NYSE:BDX ) , a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, today announced a ...
Why Becton Dickinson ( BDX ) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience
BDX partners with Henry Ford Health to deploy BD Rowa Vmax robots, aiming to streamline 24/7 pharmacy access in Michigan.
This Biogen Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Becton Dickinson ( NYSE:BDX ) , Biogen ( NASDAQ:BIIB )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer?
Hologic set to end sales of Fluoroscan InSight FD in 2025 but sees strong momentum from DXA systems and broader business growth.
Here's Why Becton Dickinson ( BDX ) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Ultimate Dividend King Drug Stock to Buy With $1,000 Right Now
This out-of-favor industry could be in the doghouse for years. Do you buy for yield or for dividend safety?
BD and Henry Ford Health Sign Pharmacy Automation Partnership to Revolutionize Medication Storage and Prescription Delivery - Becton Dickinson ( NYSE:BDX )
FRANKLIN LAKES, N.J., Sept. 22, 2025 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) BDX, a leading global medical technology company, today announced a pharmacy automation partnership with Henry Ford Health to develop the health system pharmacy of the future, with an initial focus on a ...
Why Becton Dickinson ( BDX ) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should Value Investors Buy Becton, Dickinson and Company ( BDX ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
SOLV Strong Q2 Results Signal Momentum: Is the Stock Worth Buying Now?
Solventum beats on Q2 earnings, raises guidance, and powers ahead with transformation despite looming tariff headwinds.
BDX vs. MMSI: Which Stock Should Value Investors Buy Now?
BDX vs. MMSI: Which Stock Is the Better Value Option?
Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds
HOLX lifts its 2025 revenue and EPS outlook on Q3 strength, tariff relief, and growth across Breast Health and GYN Surgical.
Are Options Traders Betting on a Big Move in Becton Dickinson Stock?
Investors need to pay close attention to Becton Dickinson stock based on the movements in the options market lately.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Becton Dickinson ( BDX ) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tesla Stock 'Could Fall 90% Tomorrow,' Fund Manager Still Won't Buy - Here's Where He's Investing Instead - Tesla ( NASDAQ:TSLA )
T. Rowe Price fund manager David Giroux warns Tesla remains severely overvalued. Giroux avoids Tesla, Palantir, Costco, Walmart; prefers healthcare, utilities, innovation picks. The market is reacting to Powell's speech. Learn how to time your next move. Details here →
[Latest] Global Chemical Reagents Market Size/Share Worth USD 26.5 Billion by 2034 at a 7.5 CAGR: Custom Market Insights ( Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis )
Austin, TX, USA, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "Chemical Reagents Market Size, Trends and Insights By Product Type ( Solvents, Acids & Bases, Oxidizing & Reducing Agents, Buffers & Standards, Catalysts ) , By Application ( ...
Biobanking Market is expected to generate a revenue of USD 2.11 Billion by 2031, Globally, at 9.89% CAGR: Verified Market Research®
Lewes, Delaware, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- The Global Biobanking Market Size is projected to grow at a CAGR of 9.89% from 2024 to 2031, according to a new report published by Verified Market Research®.
Looking Into Becton Dickinson's Recent Short Interest - Becton Dickinson ( NYSE:BDX )
Becton Dickinson's BDX short percent of float has risen 16.67% since its last report. The company recently reported that it has 5.48 million shares sold short, which is 1.89% of all regular shares that are available for trading.
Here's Why Becton Dickinson ( BDX ) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Becton Dickinson ( BDX ) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Can Sustained Product Demand Drive CAH Stock Before Q4 Earnings?
The continued solid uptake of Cardinal Health's products is expected to have driven fiscal fourth-quarter revenues despite an uncertain macroeconomic environment.
Company News for Aug 8, 2025
Companies in The Business Are: ...
Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results - Embecta ( NASDAQ:EMBC )
PARSIPPANY, N.J., Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- Embecta Corp. ( "embecta" or the "Company" ) EMBC, a global diabetes care company, today reported financial results for the three and nine month periods ended June 30, 2025.
Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results
PARSIPPANY, N.J., Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- Embecta Corp. ( "embecta" or the "Company" ) ( Nasdaq: EMBC ) , a global diabetes care company, today reported financial results for the three and nine month periods ended June 30, 2025.
Becton Dickinson Q3 Beats Estimates On Medical Device Boom - Becton Dickinson ( NYSE:BDX )
Becton Dickinson Q3 EPS of $3.68 beats estimate of $3.41; revenue rose 10.4% to $5.51 billion. BD raises FY25 EPS guidance to $14.30-$14.45 vs consensus of $14.18. Get special access to three exclusive "Top 10 Stocks" power lists today, updated daily.
Applovin, Sunrun, Duolingo, Tutor Perini, Installed Building Products And Other Big Stocks Moving Higher On Thursday - AppLovin ( NASDAQ:APP ) , Advanced Micro Devices ( NASDAQ:AMD )
U.S. stocks were mixed, with the Dow Jones index falling around 200 points on Thursday. Shares of Applovin Corp APP rose sharply during Thursday's session following upbeat earnings. AppLovin reported second-quarter revenue of $1.26 billion, missing analyst estimates of $1.31 billion, according ...
